- FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro
Audrey Joannes et al, 2016, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef - Introducing, OncoTarget
Mikhail Blagosklonny et al, 2010, Oncotarget CrossRef - Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Beatriz Ballester et al, 2019, International Journal of Molecular Sciences CrossRef - Identification of circRNA–miRNA–Immune-Related mRNA Regulatory Network in Gastric Cancer
Zhenhai Wu et al, 2022, Frontiers in Oncology CrossRef - Anti-Cancer Effect of Cordycepin on FGF9-Induced Testicular Tumorigenesis
Ming-Min Chang et al, 2020, International Journal of Molecular Sciences CrossRef - miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)
Xi He et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef - FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma
Lisha Qi et al, 2016, Oncotarget CrossRef - Gubenyiliu II Inhibits Breast Tumor Growth and Metastasis Associated with Decreased Heparanase Expression and Phosphorylation of ERK and AKT Pathways
Yi Zhang et al, 2017, Molecules CrossRef - Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition
Josine M. Quispel-Janssen et al, 2018, Clinical Cancer Research CrossRef - The anti-apoptotic and prognostic value of fibroblast growth factor 9 in gastric cancer
Chuanli Ren et al, 2016, Oncotarget CrossRef - Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al, 2020, International Journal of Molecular Sciences CrossRef - Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
Mehdi Sanati et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef - Mechanisms of multidrug resistance in cancer
Fatemeh Zahedipour et al, 2023, Aptamers Engineered Nanocarriers for Cancer Therapy CrossRef